What is the ESG rating for BMY?

Bristol-Myers Squibb Company has the following ESG ratings: MSCI ESG Rating: 75.4.

What are the key financial metrics for BMY?

Key financial metrics for Bristol-Myers Squibb Company include: Market Cap: $9741.93 billion, Dividend Yield: 5.18%.

Real-time data provided by Alpha Vantage

Market Cap

$215.4B

P/E Ratio

N/A

52-Week High

$265.41

52-Week Low

$165.41

Volume

5,062,530

Average Volume

N/A

Dividend Yield

250.00%

Beta

N/A

Market Cap$215.4B

P/E Ratio (TTM)N/A

Volume5,062,530

Avg VolumeN/A

52-Week High$265.41

52-Week Low$165.41

Dividend Yield250.00%

BetaN/A

Overall ESG Score66.0/100

Environmental72.0/100

Social73.0/100

Governance85.0/100

Peer GroupPharmaceuticals

Updated: 6/11/2025

BMY Inc.

BMY

$215.41